You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
The type 2 diabetes epidemic has reached an estimated 125 million people worldwide. This number is expected to increase to 220 million by the year 2010. The main reasons for this steep increase include reduced physical exercise, dietary changes and a higher incidence of obesity.
The world's pharmaceutical businesses compete fiercely for a part of the U.S. type 2 market of 14 million people. With this increasing prevalence, more and more type 2 medications have been approved by the U.S. Food and Drug Administration or are currently being designed to treat type 2 diabetes.
Type 2 medications run the gamut. Some drugs treat insulin resistance, in which the pancreas produces an adequate amount of insulin, but they can't properly use it. Other drugs slow carbohydrate digestion there by lowering drug sugars.
Types of Type 2 Drugs
Glyburide, Glucotrol XL, DiaBeta and others (see chart on pg. 50) are drugs that make the pancreas work harder to produce more insulin.
Avandia and ACTOS (see chart) are generally prescribed for people with insulin resistance.
Glucophage (see chart) slows the liver's production of sugar during the night and tends to make the muscles a little more sensitive to the glucose uptake.
Know Your Body
Since no two type 2s are alike, there is a different prescription for different type 2s.
Knowing your own body and the drug's specific function can help you understand your doctor's prescription, and lead to better treatment of your diabetes.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.